Skip to main content

CFO of gene editing biotech Editas leaving for Bain

Andrew Hack will return to the investment industry as a managing director at Bain Capital.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.